| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.826 | 0.004 | 0.847 | Anticonvulsant | 0.583 0.008 DBMET01794 0.847 0.004 DBMET01238 0.832 0.004 DBMET01239 0.775 0.004 DBMET01242 0.701 0.005 DBMET01241 | DBMET01238 | |
| 0.718 | 0.001 | 0.718 | Benzodiazepine receptor peripheral-type antagonist | 0.345 0.001 DBMET01794 0.469 0.001 DBMET01238 0.456 0.001 DBMET01239 0.478 0.001 DBMET01242 0.474 0.001 DBMET01241 | ||
| 0.592 | 0.001 | 0.592 | Benzodiazepine antagonist | 0.088 0.004 DBMET01794 0.245 0.002 DBMET01238 0.205 0.003 DBMET01239 0.303 0.002 DBMET01242 0.299 0.002 DBMET01241 | ||
| 0.492 | 0.003 | 0.492 | GABA A receptor antagonist | 0.216 0.005 DBMET01794 0.366 0.004 DBMET01238 0.354 0.004 DBMET01239 0.298 0.004 DBMET01242 0.236 0.005 DBMET01241 | ||
| 0.468 | 0.003 | 0.468 | GABA receptor antagonist | 0.218 0.005 DBMET01794 0.362 0.004 DBMET01238 0.347 0.004 DBMET01239 0.316 0.004 DBMET01242 0.239 0.005 DBMET01241 | ||
| 0.458 | 0.062 | 0.458 | Analgesic | 0.262 0.173 DBMET01794 0.365 0.101 DBMET01238 0.319 0.128 DBMET01239 0.389 0.089 DBMET01242 0.37 0.098 DBMET01241 | ||
| 0.408 | 0.017 | 0.414 | Transcription factor STAT inhibitor | 0.355 0.032 DBMET01794 0.369 0.027 DBMET01238 0.392 0.021 DBMET01239 0.414 0.016 DBMET01242 0.365 0.029 DBMET01241 | DBMET01242 | |
| 0.354 | 0.003 | 0.354 | Benzodiazepine agonist | 0.126 0.014 DBMET01794 0.264 0.004 DBMET01238 0.188 0.005 DBMET01239 0.169 0.005 DBMET01242 0.156 0.007 DBMET01241 | ||
| 0.347 | 0.005 | 0.383 | GABA receptor agonist | 0.273 0.008 DBMET01794 0.308 0.006 DBMET01238 0.383 0.005 DBMET01239 0.267 0.009 DBMET01242 0.233 0.012 DBMET01241 | DBMET01239 | |
| 0.315 | 0.004 | 0.333 | GABA A receptor agonist | 0.223 0.008 DBMET01794 0.271 0.005 DBMET01238 0.333 0.004 DBMET01239 0.21 0.009 DBMET01242 0.177 0.012 DBMET01241 | DBMET01239 | |
| 0.329 | 0.041 | 0.353 | Transcription factor STAT3 inhibitor | 0.312 0.048 DBMET01794 0.304 0.052 DBMET01238 0.328 0.041 DBMET01239 0.353 0.032 DBMET01242 0.301 0.053 DBMET01241 | DBMET01242 | |
| 0.362 | 0.138 | 0.366 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.334 0.169 DBMET01242 0.366 0.133 DBMET01241 | DBMET01241 | |
| 0.312 | 0.152 | 0.504 | 5 Hydroxytryptamine release inhibitor | 0.248 0.231 DBMET01239 0.408 0.073 DBMET01242 0.504 0.031 DBMET01241 | DBMET01241 | |
| 0.166 | 0.018 | 0.166 | Hedgehog signaling inhibitor | 0.123 0.038 DBMET01238 0.104 0.058 DBMET01242 | ||
| 0.182 | 0.037 | 0.209 | Neurotrophic factor | 0.172 0.043 DBMET01794 0.191 0.032 DBMET01238 0.209 0.024 DBMET01239 0.194 0.03 DBMET01242 0.193 0.031 DBMET01241 | DBMET01239 | |
| 0.165 | 0.041 | 0.174 | Glutamate receptor antagonist | 0.125 0.069 DBMET01238 0.115 0.079 DBMET01239 0.174 0.036 DBMET01242 0.173 0.037 DBMET01241 | DBMET01242 | |
| 0.139 | 0.033 | 0.139 | Transcription factor STAT6 inhibitor | 0.105 0.093 DBMET01242 | ||
| 0.279 | 0.175 | 0.429 | Calcium channel L-type activator | 0.429 0.062 DBMET01794 0.428 0.064 DBMET01238 0.428 0.064 DBMET01239 0.375 0.099 DBMET01242 0.375 0.099 DBMET01241 | DBMET01794 | |
| 0.201 | 0.114 | 0.308 | DNA damaging | 0.21 0.108 DBMET01794 0.244 0.084 DBMET01238 0.308 0.054 DBMET01239 0.168 0.148 DBMET01242 0.179 0.135 DBMET01241 | DBMET01239 | |
| 0.105 | 0.027 | 0.105 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.095 0.03 DBMET01794 0.066 0.057 DBMET01238 0.084 0.038 DBMET01239 | ||
| 0.119 | 0.057 | 0.119 | Sphingosine 1-phosphate receptor 2 agonist | 0.105 0.088 DBMET01238 0.104 0.091 DBMET01239 0.104 0.09 DBMET01241 | ||
| 0.082 | 0.025 | 0.082 | Orexin receptor antagonist | |||
| 0.089 | 0.037 | 0.089 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.155 | 0.109 | 0.183 | Anesthetic general | 0.147 0.117 DBMET01238 0.183 0.085 DBMET01242 | DBMET01242 | |
| 0.082 | 0.036 | 0.082 | Glutamate (mGluR group I) antagonist | |||
| 0.05 | 0.007 | 0.068 | Kainate receptor 4 antagonist | 0.028 0.015 DBMET01794 0.036 0.011 DBMET01238 0.037 0.01 DBMET01239 0.056 0.006 DBMET01242 0.068 0.005 DBMET01241 | DBMET01241 | |
| 0.086 | 0.044 | 0.086 | Glutamate (mGluR) antagonist | |||
| 0.055 | 0.015 | 0.055 | GABA B receptor antagonist | 0.044 0.027 DBMET01238 0.055 0.015 DBMET01242 0.043 0.03 DBMET01241 | ||
| 0.052 | 0.014 | 0.055 | Vascular adhesion protein 1 inhibitor | 0.039 0.026 DBMET01238 0.055 0.012 DBMET01239 | DBMET01239 | |
| 0.077 | 0.04 | 0.077 | Orexin receptor 1 antagonist | |||
| 0.096 | 0.06 | 0.096 | Phosphodiesterase 6D inhibitor | |||
| 0.058 | 0.023 | 0.058 | Glutamate (mGluR5) antagonist | |||
| 0.053 | 0.018 | 0.076 | Guanylate cyclase stimulant | 0.052 0.019 DBMET01238 0.076 0.009 DBMET01242 0.054 0.017 DBMET01241 | DBMET01242 | |
| 0.1 | 0.066 | 0.115 | Gastric antisecretory | 0.115 0.048 DBMET01794 0.099 0.067 DBMET01238 0.087 0.082 DBMET01242 | DBMET01794 | |
| 0.059 | 0.027 | 0.182 | H+/K+-transporting ATPase inhibitor | 0.182 0.005 DBMET01794 0.055 0.03 DBMET01238 | DBMET01794 | |
| 0.084 | 0.052 | 0.084 | Caspase 7 inhibitor | |||
| 0.06 | 0.031 | 0.06 | NMDA 2B receptor antagonist | |||
| 0.13 | 0.103 | 0.13 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.213 | 0.191 | 0.213 | GABA C receptor rho-3 antagonist | |||
| 0.046 | 0.024 | 0.056 | Nerve growth factor antagonist | 0.056 0.012 DBMET01242 0.055 0.013 DBMET01241 | DBMET01242 | |
| 0.029 | 0.007 | 0.033 | Guanylate cyclase 1 stimulant | 0.024 0.009 DBMET01238 0.033 0.006 DBMET01242 0.018 0.015 DBMET01241 | DBMET01242 | |
| 0.101 | 0.083 | 0.101 | Activin receptor-like kinase 4 inhibitor | |||
| 0.118 | 0.1 | 0.118 | Nav1.6 sodium channel blocker | |||
| 0.028 | 0.01 | 0.062 | Kainate receptor 5 antagonist | 0.019 0.016 DBMET01238 0.02 0.015 DBMET01239 0.051 0.005 DBMET01242 0.062 0.005 DBMET01241 | DBMET01241 | |
| 0.066 | 0.05 | 0.067 | Glutamate (mGluR7) antagonist | 0.067 0.048 DBMET01241 | DBMET01241 | |
| 0.022 | 0.008 | 0.044 | Kainate receptor 3 antagonist | 0.017 0.012 DBMET01238 0.017 0.012 DBMET01239 0.029 0.005 DBMET01242 0.044 0.004 DBMET01241 | DBMET01241 | |
| 0.037 | 0.024 | 0.037 | Orexin receptor 2 antagonist | |||
| 0.066 | 0.055 | 0.066 | Transforming growth factor antagonist | |||
| 0.041 | 0.032 | 0.058 | Angiotensin AT1 receptor antagonist | 0.049 0.019 DBMET01238 0.04 0.034 DBMET01239 0.058 0.008 DBMET01242 0.056 0.01 DBMET01241 | DBMET01242 | |
| 0.033 | 0.025 | 0.033 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.164 | 0.156 | 0.164 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.128 | 0.124 | 0.157 | CF transmembrane conductance regulator agonist | 0.157 0.064 DBMET01794 0.136 0.104 DBMET01238 0.14 0.094 DBMET01239 | DBMET01794 | |
| 0.026 | 0.024 | 0.026 | Glucosylceramidase stimulant | |||
| 0.092 | 0.091 | 0.092 | Anesthetic local | 0.092 0.091 DBMET01238 | ||
| 0.117 | 0.12 | 0.232 | NOS3 expression enhancer | 0.119 0.118 DBMET01239 0.141 0.082 DBMET01242 0.232 0.031 DBMET01241 | DBMET01241 | |
| 0.03 | 0.034 | 0.048 | Angiotensin II receptor antagonist | 0.037 0.019 DBMET01238 0.048 0.008 DBMET01242 0.045 0.009 DBMET01241 | DBMET01242 | |
| 0.085 | 0.089 | 0.219 | Ferrochelatase inhibitor | 0.219 0.018 DBMET01242 0.165 0.032 DBMET01241 | DBMET01242 | |
| 0.044 | 0.049 | 0.052 | Toll-Like receptor 8 antagonist | 0.048 0.044 DBMET01238 0.052 0.039 DBMET01239 | DBMET01239 | |
| 0.095 | 0.107 | 0.137 | TRKB antagonist | 0.137 0.055 DBMET01239 | DBMET01239 | |
| 0.015 | 0.031 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.021 0.017 DBMET01794 0.025 0.012 DBMET01242 0.023 0.014 DBMET01241 | DBMET01242 | |
| 0.016 | 0.041 | 0.03 | AMPA 2 receptor antagonist | 0.03 0.021 DBMET01242 0.029 0.021 DBMET01241 | DBMET01242 | |
| 0.03 | 0.057 | 0.05 | Guanylate cyclase inhibitor | 0.039 0.035 DBMET01238 0.05 0.021 DBMET01239 0.045 0.027 DBMET01241 | DBMET01239 | |
| 0.186 | 0.22 | 0.451 | Histamine release inhibitor | 0.248 0.157 DBMET01239 0.423 0.064 DBMET01242 0.451 0.05 DBMET01241 | DBMET01241 | |
| 0.096 | 0.133 | 0.11 | Antibacterial (Helicobacter pylori) | 0.11 0.097 DBMET01794 0.109 0.1 DBMET01241 | DBMET01794 | |
| 0.225 | 0.285 | 0.286 | Caspase 9 stimulant | 0.286 0.21 DBMET01238 0.286 0.21 DBMET01239 | DBMET01239 | |
| 0.08 | 0.143 | 0.121 | Aldehyde dehydrogenase inhibitor | 0.106 0.089 DBMET01238 0.104 0.091 DBMET01239 0.121 0.07 DBMET01242 0.111 0.081 DBMET01241 | DBMET01242 | |
| 0.032 | 0.099 | 0.091 | Biliverdin reductase inhibitor | 0.091 0.021 DBMET01242 0.069 0.033 DBMET01241 | DBMET01242 | |
| 0.038 | 0.117 | 0.126 | Porphobilinogen synthase inhibitor | 0.099 0.036 DBMET01794 0.067 0.058 DBMET01238 0.067 0.058 DBMET01239 0.126 0.026 DBMET01242 0.089 0.042 DBMET01241 | DBMET01242 | |
| 0.042 | 0.123 | 0.064 | Histone deacetylase SIRT1 stimulant | 0.064 0.062 DBMET01241 | DBMET01241 | |
| 0.042 | 0.123 | 0.064 | Histone deacetylase stimulant | 0.064 0.062 DBMET01241 | DBMET01241 | |
| 0.045 | 0.136 | 0.109 | Potassium channel (Ca-activated) activator | 0.109 0.048 DBMET01242 0.091 0.063 DBMET01241 | DBMET01242 | |
| 0.011 | 0.103 | 0.042 | Kainate receptor 2 antagonist | 0.042 0.02 DBMET01241 | DBMET01241 | |
| 0.027 | 0.158 | 0.045 | Topoisomerase II beta inhibitor | 0.045 0.042 DBMET01794 | DBMET01794 | |
| 0.025 | 0.157 | 0.045 | Glutamate (mGluR group III) antagonist | 0.045 0.028 DBMET01241 | DBMET01241 | |
| 0.088 | 0.223 | 0.184 | Insulin sensitizer | 0.157 0.123 DBMET01242 0.184 0.09 DBMET01241 | DBMET01241 | |
| 0.028 | 0.174 | 0.049 | Autotaxin inhibitor | 0.049 0.043 DBMET01794 0.048 0.046 DBMET01242 | DBMET01794 | |
| 0.008 | 0.161 | 0.04 | Kainate receptor antagonist | 0.04 0.029 DBMET01241 | DBMET01241 | |
| 0.036 | 0.19 | 0.066 | Glutamate dehydrogenase inhibitor | 0.066 0.064 DBMET01242 | DBMET01242 | |
| 0.011 | 0.17 | 0.033 | Purinergic P2Y14 antagonist | 0.033 0.017 DBMET01242 | DBMET01242 | |
| 0.109 | 0.273 | 0.129 | Ca2+-transporting ATPase inhibitor | 0.129 0.124 DBMET01242 | DBMET01242 | |
| 0.134 | 0.3 | 0.209 | Antiobesity | 0.209 0.198 DBMET01241 | DBMET01241 | |
| 0.057 | 0.236 | 0.097 | Interleukin 12 antagonist | 0.097 0.059 DBMET01239 | DBMET01239 | |
| 0.041 | 0.226 | 0.11 | Uric acid excretion stimulant | 0.11 0.045 DBMET01242 0.103 0.05 DBMET01241 | DBMET01242 | |
| 0.041 | 0.24 | 0.1 | Chelator | 0.1 0.078 DBMET01794 0.091 0.09 DBMET01241 | DBMET01794 | |
| 0.151 | 0.357 | 0.281 | Apoptosis agonist | 0.281 0.187 DBMET01794 | DBMET01794 | |
| 0.046 | 0.265 | 0.117 | Alpha-N-acetylglucosaminidase inhibitor | 0.117 0.081 DBMET01242 | DBMET01242 | |
| 0.103 | 0.348 | 0.196 | Immunomodulator | 0.188 0.179 DBMET01794 0.196 0.169 DBMET01239 | DBMET01239 | |
| 0.067 | 0.364 | 0.141 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.141 0.091 DBMET01242 | DBMET01242 | |
| 0.004 | 0.324 | 0.023 | Retinoid X gamma receptor agonist | 0.023 0.016 DBMET01241 | DBMET01241 | |
| 0.091 | 0.418 | 0.215 | Antibacterial | 0.215 0.212 DBMET01241 | DBMET01241 | |
| 0.07 | 0.41 | 0.151 | Lipocortins synthesis antagonist | 0.151 0.103 DBMET01242 | DBMET01242 | |
| 0.103 | 0.522 | 0.271 | Antiinflammatory | 0.271 0.244 DBMET01794 | DBMET01794 | |
| 0.083 | 0.525 | 0.288 | Cyclophilin D inhibitor | 0.238 0.226 DBMET01238 0.233 0.232 DBMET01242 0.288 0.174 DBMET01241 | DBMET01241 | |
| 0.008 | 0.493 | 0.04 | Retinoic acid alpha receptor agonist | 0.04 0.025 DBMET01242 0.037 0.03 DBMET01241 | DBMET01242 | |
| 0.064 | 0.71 | 0.253 | Interleukin 2 agonist | 0.253 0.115 DBMET01794 0.218 0.16 DBMET01238 0.218 0.16 DBMET01239 | DBMET01794 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |